EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bovine Milk–Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges

Martina Brattini, Michelle D'Urso, Sofia Mariotto iD, Elena Butturini

Journal of Extracellular Biology · 2026-07 · 5 (7)

DOI: 10.1002/jex2.70160 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Extracellular Biology, online erschienen am 27.06.2026. Verfasst von Martina Brattini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biomedicine and Movement Science Section of Biological Chemistry University of Verona Verona Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are nanosized lipid bilayer particles naturally secreted by cells, mediating intercellular communication and transporting diverse bioactive molecules. Among alternative EV sources, bovine milk‐derived EVs (BMEVs) have emerged as promising platforms for drug delivery due to their accessibility, scalability, stability and promising biocompatibility, although their long‐term safety profile, particularly for engineered or cargo‐loaded formulations, still requires further investigation. BMEVs can encapsulate small molecules, natural polyphenols and nucleic acids, enhancing bioavailability, protecting cargo from degradation and facilitating functional delivery. Recent studies demonstrate their potential for oral administration and their intrinsic therapeutic properties, including antioxidant, anti‐inflammatory, and immunomodulatory activities. Moreover, the increasing number of patents highlights their translational and commercial relevance in therapeutic, cosmetic and nutraceutical applications. Despite these promising features, challenges remain in standardizing isolation protocols, optimizing cargo loading, ensuring batch reproducibility and evaluating long‐term safety. Addressing these gaps is essential to enable clinical translation and establish BMEVs as versatile drug delivery platforms. Trial Registration : ClinicalTrials.gov identifier: NCT07402083

Schlagwörter

Stichwörter der Autor:innen

drug deliveryextracellular vesiclesmilk

Autor:innen und Institutionen

  • Department of Neuroscience, Biomedicine and Movement Science Section of Biological Chemistry University of Verona Verona Italy.

ORCID-Profile: Sofia Mariotto

Zitieren

APA

Brattini, M., D'Urso, M., Mariotto, S., & Butturini, E. (2026). Bovine Milk–Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges. Journal of Extracellular Biology, 5(7). https://doi.org/10.1002/jex2.70160

Vancouver

Brattini M, D'Urso M, Mariotto S, Butturini E. Bovine Milk–Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges. Journal of Extracellular Biology. 2026;5(7). doi:10.1002/jex2.70160

BibTeX
@article{Brattini2026,
  author = {Brattini, Martina and D'Urso, Michelle and Mariotto, Sofia and Butturini, Elena},
  title = {Bovine Milk–Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges},
  journal = {Journal of Extracellular Biology},
  year = {2026},
  volume = {5},
  number = {7},
  doi = {10.1002/jex2.70160}
}
Kostenlos starten →